FTIR and nDSC as analytical tools for high-concentration protein formulations

被引:100
作者
Matheus, Susanne
Friess, Wolfgang
Mahler, Hanns-Christian
机构
[1] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, Munich, Germany
[2] Mercl KGaA, Global Pharmaceut Dev, Darmstadt, Germany
关键词
DSC; formulation development; FTIR; high-concentration protein formulation; melting temperature;
D O I
10.1007/s11095-006-0142-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of the study is to evaluate Fourier-transform infrared spectroscopy (FTIR) as an analytical tool for high-concentrated protein formulations. Methods. FTIR is used to determine the melting temperature (T-m (FTIR)) of various proteins, such as bovine serum albumin (BSA), immunoglobulin (IgG(1)), beta-lactoglobulin (beta-LG), and lysozyme (HEWL), at different protein concentrations (5-100 mg/mL), where four data interpretation methods are discussed. The obtained T-m (FTIR) values are further compared to the T-m measured by the nanodifferential scanning calorimetry (nDSC) technique. Results. The T-m (FTIR) values of IgG(1) and beta-LG showed strong consistency and corresponded to the nDSC results irrespective of the method of data interpretation and the protein concentration applied. In contrast, the T-m (FTIR) of BSA and HEWL is characterized by significant deviations. Only the midpoint of the second-derivative intensity-temperature curve of the intermolecular beta-sheet mode measured at a concentration of 100 mg/mL is consistent with the nDSC results. Conclusions. Determination of a T-m (FTIR) is feasible by the midpoint of the intensity-temperature plot of the arising intermolecular beta-sheet band. More significant results are obtained for proteins, which are predominantly composed of intramolecular beta-sheet elements as well as at higher protein concentrations. A further study was started to assess the predictability of long-term protein stability by T-m (FTIR).
引用
收藏
页码:1350 / 1363
页数:14
相关论文
共 78 条
[1]   QUANTITATIVE STUDIES OF THE STRUCTURE OF PROTEINS IN SOLUTION BY FOURIER-TRANSFORM INFRARED-SPECTROSCOPY [J].
ARRONDO, JLR ;
MUGA, A ;
CASTRESANA, J ;
GONI, FM .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1993, 59 (01) :23-56
[2]   PROTEIN STABILITY CURVES [J].
BECKTEL, WJ ;
SCHELLMAN, JA .
BIOPOLYMERS, 1987, 26 (11) :1859-1877
[3]   Structural changes of β-lactoglobulin during thermal unfolding and refolding -: An FT-IR and circular dichroism study [J].
Bhattacharjee, C ;
Saha, S ;
Biswas, A ;
Kundu, M ;
Ghosh, L ;
Das, KP .
PROTEIN JOURNAL, 2005, 24 (01) :27-35
[4]  
Bummer PM., 2000, DRUGS PHARM SCI, P5
[5]   EXAMINATION OF THE SECONDARY STRUCTURE OF PROTEINS BY DECONVOLVED FTIR SPECTRA [J].
BYLER, DM ;
SUSI, H .
BIOPOLYMERS, 1986, 25 (03) :469-487
[6]   Application of infrared spectroscopy to development of stable lyophilized protein formulations [J].
Carpenter, JF ;
Prestrelski, SJ ;
Dong, AC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :231-238
[7]  
Carpenter JF, 1999, METHOD ENZYMOL, V309, P236
[8]   AN INFRARED SPECTROSCOPIC STUDY OF THE INTERACTIONS OF CARBOHYDRATES WITH DRIED PROTEINS [J].
CARPENTER, JF ;
CROWE, JH .
BIOCHEMISTRY, 1989, 28 (09) :3916-3922
[9]   Thermal stability: A means to assure tertiary structure in therapeutic proteins [J].
Cauchy, M ;
D'Aoust, S ;
Dawson, B ;
Rode, H ;
Hefford, MA .
BIOLOGICALS, 2002, 30 (03) :175-185
[10]   THERMAL-ANALYSIS OF PROTEINS OF PHARMACEUTICAL INTEREST [J].
CHEN, T ;
OAKLEY, DM .
THERMOCHIMICA ACTA, 1995, 248 :229-244